Mabwell (shanghai) Bioscience Co., Ltd.
Clinical trials sponsored by Mabwell (shanghai) Bioscience Co., Ltd., explained in plain language.
-
New drug 9MW1911 tested for safety in first human trial
Disease control CompletedThis Phase 1 trial tested the safety and tolerability of a new drug called 9MW1911 in 48 healthy adults. Participants received either the drug or a placebo by IV infusion. The study aims to find the maximum safe dose and understand how the drug moves through the body. This is ear…
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
First human tests begin for potential lung and tumor drug
Knowledge-focused CompletedThis study tested a new drug called 9MW3811 for the first time in humans. The main goal was to check if it is safe and how well it is tolerated in 32 healthy adults aged 18 to 55. Researchers gave a single dose and monitored for side effects, measuring how the drug moves through …
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC